Vericel Corp. Stock
Your prediction
Vericel Corp. Stock
Heavy losses for Vericel Corp. today as the stock fell by -€1.000 (-3.180%).
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for Vericel Corp. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of Vericel Corp. in the next few years
Pros
?
B****
?
G***** c******* t* c**********
?
S********** s********
Cons
?
M***** P*******
?
C******** o* t** e**********
?
W********* I********* f** t** n*** y****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Vericel Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Vericel Corp. | -3.180% | 5.960% | 0.629% | -35.223% | 1.266% | 11.576% | -17.184% |
| Rockwell Medical Inc. | -1.210% | -10.649% | -18.068% | -50.969% | 15.965% | -60.775% | -93.852% |
| Pacira Pharmaceuticals | -3.030% | 2.717% | 8.621% | -19.915% | -12.500% | -51.036% | -68.235% |
| Twist Bioscience Corp | 2.280% | -9.854% | 15.548% | 8.277% | 50.772% | 131.121% | -62.171% |
Comments
News
Brown Capital Discloses $31 Million Sale of Vericel Stock as Small-Cap Biotech Reports Earnings
On Tuesday, Baltimore-based Brown Capital Management reported selling 861,020 shares of Vericel Corporation for an estimated $30.9 million based on the average share price in the third quarter.
